BlackRock Health Sciences Net Income

BMEZ Stock  USD 15.05  0.03  0.20%   
As of the 27th of February, BlackRock Health shows the risk adjusted performance of 0.0662, and Mean Deviation of 0.7268. BlackRock Health Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

BlackRock Health Total Revenue

24.66 Million

BlackRock Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BlackRock Health's valuation are provided below:
Market Capitalization
1.5 B
Enterprise Value Revenue
53.7582
Earnings Share
(0.12)
We have found one hundred nineteen available fundamental signals for BlackRock Health Sciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of BlackRock Health Sciences prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 223.9 M in 2026. Enterprise Value is likely to drop to about 224 M in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Income From Continuing Ops1.7 B879 M
Net Income21.1 M20.1 M
Net Income Per Share 1.59  1.67 
Net Income Per Share is likely to rise to 1.67 in 2026, whereas Net Income From Continuing Ops is likely to drop slightly above 879 M in 2026.
  
Build AI portfolio with BlackRock Stock
The evolution of Net Income for BlackRock Health Sciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how BlackRock Health compares to historical norms and industry peers.

Latest BlackRock Health's Net Income Growth Pattern

Below is the plot of the Net Income of BlackRock Health Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in BlackRock Health Sciences financial statement analysis. It represents the amount of money remaining after all of BlackRock Health Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is BlackRock Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BlackRock Health's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 23.45 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

BlackRock Net Income Regression Statistics

Arithmetic Mean79,113,966
Coefficient Of Variation59.13
Mean Deviation40,188,211
Median113,229,299
Standard Deviation46,779,435
Sample Variance2188.3T
Range139.7M
R-Value(0.81)
Mean Square Error807.2T
R-Squared0.65
Significance0.000085
Slope(7,492,683)
Total Sum of Squares35013T

BlackRock Net Income History

202635.9 M
202521.1 M
202423.5 M
202320 M
2022-26.5 M
202159.1 M
202079.6 M

Other Fundumenentals of BlackRock Health Sciences

BlackRock Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for BlackRock Health is extremely important. It helps to project a fair market value of BlackRock Stock properly, considering its historical fundamentals such as Net Income. Since BlackRock Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BlackRock Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BlackRock Health's interrelated accounts and indicators.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BlackRock Health. Projected growth potential of BlackRock fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive BlackRock Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.12)
Investors evaluate BlackRock Health Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BlackRock Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause BlackRock Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between BlackRock Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BlackRock Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BlackRock Health's market price signifies the transaction level at which participants voluntarily complete trades.

BlackRock Health 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BlackRock Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BlackRock Health.
0.00
11/29/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/27/2026
0.00
If you would invest  0.00  in BlackRock Health on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding BlackRock Health Sciences or generate 0.0% return on investment in BlackRock Health over 90 days. BlackRock Health is related to or competes with BlackRock Capital, BlackRock ESG, BlackRock Science, Blackrock Municipal, World Growth, Blackrock Enhanced, and Schwab Target. BlackRock Health is entity of United States More

BlackRock Health Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BlackRock Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BlackRock Health Sciences upside and downside potential and time the market with a certain degree of confidence.

BlackRock Health Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for BlackRock Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BlackRock Health's standard deviation. In reality, there are many statistical measures that can use BlackRock Health historical prices to predict the future BlackRock Health's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BlackRock Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
14.1915.0515.91
Details
Intrinsic
Valuation
LowRealHigh
14.2415.0915.95
Details
Naive
Forecast
LowNextHigh
14.4815.3416.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
12.4615.0015.13
Details

BlackRock Health February 27, 2026 Technical Indicators

BlackRock Health Sciences Backtested Returns

At this stage we consider BlackRock Stock to be very steady. BlackRock Health Sciences secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for BlackRock Health Sciences, which you can use to evaluate the volatility of the firm. Please confirm BlackRock Health's risk adjusted performance of 0.0662, and Mean Deviation of 0.7268 to double-check if the risk estimate we provide is consistent with the expected return of 0.0014%. The firm shows a Beta (market volatility) of 0.0308, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BlackRock Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding BlackRock Health is expected to be smaller as well. BlackRock Health Sciences right now shows a risk of 0.86%. Please confirm BlackRock Health Sciences value at risk, and the relationship between the standard deviation and kurtosis , to decide if BlackRock Health Sciences will be following its price patterns.

Auto-correlation

    
  -0.07  

Very weak reverse predictability

BlackRock Health Sciences has very weak reverse predictability. Overlapping area represents the amount of predictability between BlackRock Health time series from 29th of November 2025 to 13th of January 2026 and 13th of January 2026 to 27th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BlackRock Health Sciences price movement. The serial correlation of -0.07 indicates that barely 7.0% of current BlackRock Health price fluctuation can be explain by its past prices.
Correlation Coefficient-0.07
Spearman Rank Test-0.28
Residual Average0.0
Price Variance0.03
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, BlackRock Health Sciences reported net income of 23.45 M. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is notably lower than that of the firm.

BlackRock Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BlackRock Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BlackRock Health could also be used in its relative valuation, which is a method of valuing BlackRock Health by comparing valuation metrics of similar companies.
BlackRock Health is currently under evaluation in net income category among its peers.

BlackRock Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of BlackRock Health from analyzing BlackRock Health's financial statements. These drivers represent accounts that assess BlackRock Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BlackRock Health's important valuation drivers and their relationship over time.
202120222023202420252026 (projected)
Market Cap3.2B2.9B194.5M205.0M235.7M223.9M
Enterprise Value3.2B2.9B195.2M205.0M235.8M224.0M

BlackRock Fundamentals

About BlackRock Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BlackRock Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BlackRock Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BlackRock Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BlackRock Stock Analysis

When running BlackRock Health's price analysis, check to measure BlackRock Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Health is operating at the current time. Most of BlackRock Health's value examination focuses on studying past and present price action to predict the probability of BlackRock Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Health's price. Additionally, you may evaluate how the addition of BlackRock Health to your portfolios can decrease your overall portfolio volatility.